CervoMed Stock (NASDAQ: CRVO) stock price, news, charts, stock research, profile.
You can purchase shares of CervoMed (NASDAQ:CRVO) through any online brokerage.
Other companies in CervoMed’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Skye Bioscience (NASDAQ:SKYE), Adverum Biotechnologies (NASDAQ:ADVM), Citius Oncology (NASDAQ:CTOR) and Adicet Bio (NASDAQ:ACET).
CervoMed has a consensus price target of $57.60.
The stock price for CervoMed (NASDAQ: CRVO) is $15.31 last updated September 26, 2024 at 4:00 PM EDT.
There are no upcoming dividends for CervoMed.
CervoMed’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for CervoMed.
CervoMed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.